Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last hours
Enjoy this offer
* See conditions on site

Valuation: Vitrolife AB

Capitalization 20.04B 2.1B 1.85B 1.73B 1.56B 2.89B 179B 3.24B 7.89B 81.97B 7.88B 7.71B 300B P/E ratio 2025 *
34.3x
P/E ratio 2026 * 27.8x
Enterprise value 20.35B 2.13B 1.88B 1.75B 1.58B 2.93B 182B 3.29B 8.01B 83.24B 8B 7.83B 304B EV / Sales 2025 *
5.51x
EV / Sales 2026 * 4.87x
Free-Float
55.41%
Yield 2025 *
0.8%
Yield 2026 * 0.95%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.87%
1 week-6.39%
Current month-6.09%
1 month-5.37%
3 months-28.16%
6 months-33.15%
Current year-31.16%
More quotes
1 week 146
Extreme 146
161.8
1 month 143.5
Extreme 143.5
163.1
Current year 142.9
Extreme 142.9
251
1 year 142.9
Extreme 142.9
268
3 years 123.9
Extreme 123.9
332.6
5 years 123.9
Extreme 123.9
585
10 years 30.3
Extreme 30.3
585
More quotes
Manager TitleAgeSince
Chief Executive Officer 51 2023-07-31
Director of Finance/CFO 60 2024-12-02
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Director/Board Member 62 2013-04-18
Chairman 69 2023-07-31
Director/Board Member 65 2018-04-26
More insiders
Name Weight AuM 1st Jan change
0.37% 240 M€ +0.35% -
More ETFs: Vitrolife AB
Change 5d. change 1-year change 3-years change Capi.($)
-0.87%-6.39%-19.83%-40.94% 2.1B
-1.61%-3.16%+22.81%+28.08% 15.55B
+0.31%+4.94%-22.11%+39.78% 6.34B
-1.66%-5.17%-8.28%-22.91% 5.51B
-1.19%-9.08%-5.57%+15.84% 5.11B
+2.56%-6.57%+48.90%+1.96% 4.71B
+0.10%-0.05%-23.74%-7.79% 3.13B
-0.60%-3.25%-6.43%-43.65% 2.53B
+0.66%+0.05%+0.97%-38.96% 1.58B
+0.23%-3.17%+4.12%+89.30% 1.49B
Average -0.21%-3.13%-0.92%+2.07% 4.8B
Weighted average by Cap. -0.58%-3.32%+5.12%+10.48%
See all sector performances

Financials

2025 *2026 *
Net sales 3.7B 387M 342M 319M 287M 533M 33B 598M 1.45B 15.12B 1.45B 1.42B 55.3B 4.03B 422M 373M 347M 313M 581M 35.97B 652M 1.59B 16.48B 1.58B 1.55B 60.29B
Net income 584M 61.25M 54.04M 50.36M 45.38M 84.29M 5.22B 94.6M 230M 2.39B 230M 225M 8.74B 720M 75.46M 66.58M 62.05M 55.91M 104M 6.43B 117M 283M 2.95B 283M 277M 10.77B
Net Debt 309M 32.4M 28.59M 26.64M 24M 44.59M 2.76B 50.04M 122M 1.26B 122M 119M 4.63B -427M -44.79M -39.52M -36.83M -33.18M -61.64M -3.82B -69.17M -168M -1.75B -168M -165M -6.39B
More financial data * Estimated data
Logo Vitrolife AB
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
Employees
1,150
More about the company
Date Price Change Volume
25-05-23 148.00 kr -0.87% 119,997
25-05-22 149.30 kr -5.21% 104,856
25-05-21 157.50 kr +0.90% 82,937
25-05-20 156.10 kr -3.34% 145,832
25-05-19 161.50 kr +2.15% 137,465

Delayed Quote Nasdaq Stockholm, May 23, 2025 at 12:00 pm EDT

More quotes
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
148.00SEK
Average target price
242.40SEK
Spread / Average Target
+63.78%
Consensus

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
BENEFIT NOW